GlassScriptPhysician profile
Lora Michelle Stephens
NPI 1609334341
$12,493.43
in general payments reported to CMS, 2019-2025
47 companies · $5,558 in 2025
The $5,558 reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,859 · 2024: $4,076 · 2025: $5,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $270 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,176.64 |
| Education | $269.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,195.80 | 2023-2025 | Briviact, Nayzilam, Rystiggo |
| Abbvie INC. | $1,000.25 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $731.45 | 2023-2025 | |
| Mdd US Operations, LLC | $715.29 | 2023-2025 | Apokyn, Gocovri, Xadago |
| Lilly USA, LLC | $690.01 | 2023-2025 | Kisunla, Amyvid, Emgality |
| Neurelis, INC. | $687.47 | 2023-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $603.33 | 2023-2025 | Nuplazid |
| Axsome Therapeutics, INC. | $566.20 | 2023-2025 | Sunosi, Symbravo, Auvelity |
| Teva Pharmaceuticals USA, INC. | $563.25 | 2023-2025 | Ajovy, Austedo Xr |
| Neurocrine Biosciences, INC. | $495.96 | 2023-2025 | Ingrezza, Ongentys |
| Eisai INC. | $488.67 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $350.15 | 2023-2025 | |
| Sk Life Science, INC. | $329.63 | 2024-2025 | |
| Pfizer INC. | $311.27 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $302.29 | 2023-2024 | Aptiom |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $295.05 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $287.04 | 2023-2025 | Vumerity, Skyclarys |
| Scilex Pharmaceuticals INC. | $259.97 | 2023-2025 | Ztlido |
| Harmony Biosciences LLC | $242.17 | 2024 | |
| Aucta Pharmaceuticals, INC. | $240.38 | 2024-2025 | Motpoly Xr |
| Otsuka America Pharmaceutical, INC. | $230.60 | 2023-2025 | Rexulti, Nuedexta |
| Lundbeck LLC | $228.97 | 2023-2025 | Vyepti, Rexulti |
| Azurity Pharmaceuticals, INC. | $190.08 | 2023-2025 | Horizant, Horizant |
| Amneal Pharmaceuticals LLC | $186.91 | 2023-2025 | Rytary, Crexont, Lyvispah |
| Impel Pharmaceuticals INC. | $158.66 | 2023 | Trudhesa |
| Idorsia Pharmaceuticals US INC | $135.96 | 2023 | Quviviq |
| Impel Pharmaceuticals LLC | $123.35 | 2024-2025 | Trudhesa |
| Astrazeneca Pharmaceuticals LP | $101.15 | 2024-2025 | Wainua |
| Takeda Pharmaceuticals U.S.A., INC. | $100.18 | 2025 | Hyqvia |
| Avadel Cns Pharmaceuticals, LLC | $98.84 | 2025 | Lumryz |
| Alexion Pharmaceuticals, INC. | $80.32 | 2023 | Ultomiris |
| Csl Behring | $57.99 | 2025 | Hizentra |
| Ani Pharmaceuticals, INC. | $47.72 | 2025 | Purified Cortrophin Gel |
| Boston Scientific Corporation | $47.20 | 2024-2025 | Watchman Flx, General - Pain Management |
| Corium, LLC | $40.16 | 2023 | Adlarity |
| Mallinckrodt Hospital Products INC. | $39.90 | 2025 | Acthar |
| Amgen INC. | $39.50 | 2023-2025 | Aimovig, Uplizna |
| Ge Healthcare | $39.04 | 2025 | |
| Octapharma USA, INC. | $30.14 | 2025 | Panzyga |
| Tg Therapeutics, INC. | $26.23 | 2025 | |
| Insightec,INC | $21.87 | 2025 | Exablate |
| Inspire Medical Systems, INC. | $21.84 | 2024 | Inspire |
| 3b Medical, INC. | $21.22 | 2025 | Luna |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $20.00 | 2025 | Rexulti |
| Upsher-Smith Laboratories LLC | $19.01 | 2023 | |
| Novo Nordisk INC | $16.26 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $14.70 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.